Correction to: Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release (Apoptosis, (2024), 29, 11-12, (2025-2046), 10.1007/s10495-024-02025-5)

Anna Shteinfer‑Kuzmine, Ankit Verma, Rut Bornshten, Eli Ben Chetrit, Ami Ben‑Ya’acov, Hadas Pahima, Ethan Rubin, Yosef Mograbi, Eyal Shteyer, Varda Shoshan‑Barmatz

Research output: Contribution to journalComment/debate

Abstract

Correction to: Elevated serum mtDNA in COVID‑19 patients is linked to SARS‑CoV‑2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release, Apoptosis (2024) 29:2025–2046. https://doi.org/10.1007/s10495-024-02025-5. In this article, Anna Shteinfer Kuzmine and Ankit Verma should have been designated as co-first authors, as both contributed equally to this work. The original article has been corrected.

Original languageEnglish
JournalApoptosis
DOIs
StateAccepted/In press - 1 Jan 2025

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Clinical Biochemistry
  • Cell Biology
  • Biochemistry, medical
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release (Apoptosis, (2024), 29, 11-12, (2025-2046), 10.1007/s10495-024-02025-5)'. Together they form a unique fingerprint.

Cite this